EPO and chronic kidney disease: While these results suggested myofibroblast transdifferentiation as the main cause of the loss of Epo expression during CKD, REP cells had been activated and tagged by a genetic background of severe congenital anaemia, limiting the relevance of this model for the investigation of renal anaemia.